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Abstract
Background:  To assess influenza vaccination coverage from 2001 to 2006 in Germany, to
understand drivers and barriers to vaccination and to identify vaccination intentions for season
2006/07.
Methods: 9,990 telephone-based household surveys from age 14 were conducted between 2001
and 2006. Essentially, the same questionnaire was used in all seasons.
Results: The influenza vaccination coverage rate reached 32.5% in 2005/06. In the elderly (≥60
years), the vaccination rate reached 58.9% in 2005/06. In those aged 65 years and older, it was
63.4%. Perceiving influenza as a serious illness was the most frequent reason for getting vaccinated.
Thirteen percent of those vaccinated in 2005/06 indicated the threat of avian flu as a reason. The
main reason for not getting vaccinated was thinking about it without putting it into practice. The
major encouraging factor to vaccination was a recommendation by the family doctor. 49.6% of the
respondents intend to get vaccinated against influenza in season 2006/07.
Conclusion: Increasing vaccination rates were observed from 2001 to 2006 in Germany. The
threat of avian influenza and the extended reimbursement programs may have contributed to the
recent increase.
Background
The severity of influenza and the efficacy of vaccination
are well documented in the medical literature. In addition
to providing substantial health benefits, vaccination may
also be associated with significant economic benefits, not
only among the elderly but also among healthy working
adults and children. Currently, the German Standing
Commission on Immunization (STIKO) recommends
influenza vaccination for persons 60 years or older, per-
sons with a chronic disease, persons with an increased
professional risk, and if a larger epidemic disease outbreak
or pandemic occurs [1]. Some federal states now offer
reimbursement of the vaccination to the entire popula-
tion [2,3]. Despite ongoing efforts by policy makers, phy-
sicians and other health care providers, influenza
vaccination rates are rarely sufficient to reduce the enor-
mous disease burden.
The WHO states that the risk of a new pandemic is on its
highest level since the last pandemic in 1968 [4]. This sit-
uation stresses the importance of high immunisation cov-
erage rates in the population.
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Previous papers have reported influenza vaccination cov-
erage rates in Germany based on cross-sectional data anal-
yses [5-9]. We have data available for five consecutive
seasons and are therefore able to extend the usual cross-
sectional approach and to measure potential correlations
and to analyse time trends in a consistent dataset.
This paper aims to analyse influenza vaccination coverage
rates and related trends over five vaccination seasons in
Germany, with a special focus on high-risk group cover-
age. The second objective is to understand the determi-
nants for being or not being vaccinated, to describe the
drivers and barriers to vaccination and to identify vaccina-
tion intentions for season 2006/07. In this context, we
examine whether the threat of avian influenza has had an
impact on vaccination coverage.
Methods
This survey is part of an ongoing international assessment
of influenza immunisation uptake in Europe (France,
Great Britain, Italy, Spain and Germany). During five
influenza seasons, 2001/02, 2002/03, 2003/04, 2004/05
and 2005/06 a population-based telephone survey was
conducted in December among German households rep-
resentative of the population. The survey included per-
sons aged 14 years and older. The agreement of the
interviewees was asked at the beginning of the call. There
was no study intervention and the anonymity of the par-
ticipants was guaranteed. Therefore, no ethical approval
was required. Data from official national sources were
used as a basis for quota which allowed ensuring the rep-
resentativeness of the actual respondents.
Four target groups based on national recommendations
were specified [1].
- Individuals aged 60 years or older
- Individuals who suffer from a chronic illness
- Individuals who work in the medical field
- Composite target group (individuals aged 60 years or
older or who suffer from a chronic illness or who work in
the medical field)
According to the German Standing Commission on
Immunization (STIKO), the group of chronic illness suf-
ferers is defined as children, adolescences and adults suf-
fering from chronic diseases of respiratory organs, chronic
cardiovascular or liver diseases, as well as nephropathies
and diabetes or other metabolic disorders [1].
The survey questions were presented in an earlier publica-
tion [9]. In the latest season, 2005/06, questions on influ-
enza pandemics and avian influenza were added.
Sample weights were applied to correct for small devia-
tions from the age and gender quota requested and the
annual datasets were pooled. Statistical evaluation used
SPSS® version 13 for Windows. Bivariate associations of
categorical variables were assessed using the Chi squared
test. A Chi squared test for trends was used to assess time
trends. In the case of continuous variables, differences of
means were tested using one-way ANOVA. For all statisti-
cal tests, two-sided p ≤ 0.05 was used as the level of statis-
tical significance. Ninety-five percent confidence intervals
(CI) were reported as appropriate. Due to the descriptive
nature of this data, no correction for multiple testing was
made. Predictor variables with strong associations were
considered candidates for multivariable analysis and
logistic regression was used to identify independent corre-
lates of the outcome of interest, i.e. vaccination coverage.
Results
Demographic data
In total 9 990 persons were interviewed. Table 1 gives an
overview of the sample. The samples were composed sim-
ilarly over the years, and were representative of the popu-
lation aged 14 years and older, in each year.
Vaccination coverage rate
Influenza vaccination coverage reached 32.5% (95% CI:
30.5%; 34.5%) in the latest season 2005/06 (see Figure
1). This uptake was significantly higher than the uptake in
season 2004/05 (p < 0.001). The first vaccination cover-
age rate measured by this series of surveys was 26.8%
(95% CI: 24.9%; 28.7%) in season 2001/02. There was a
decrease to 22.2% (95% CI: 20.4%; 24.0%) in season
2002/03. Thereafter, the coverage increased to 25.0%
(95% CI: 23.1%; 26.9%) in season 2003/04 and to 26.4%
(95% CI: 24.4%; 28.3%) in season 2004/05.
With respect to the coming winter of 2006/07, 49.6% of
the respondents intend to get vaccinated against influenza
(Fig. 1). In season 2005/06 47.9% of the German popula-
tion intended to get vaccinated.
In the season 2005/06, the proportion of vaccinated per-
sons who had also been vaccinated in the past increased
to 29%, the highest rate in this time series (minimum,
20% in season 2002/03; p for trend across seasons
<0.001). The proportion of first time immunisations
remained essentially stable over time and was 4% in sea-
son 2005/06. In contrast, the proportion of persons who
had been vaccinated in the past, but not in this season, as
well as the proportion of persons who had never been vac-
cinated before reached minimums of 20% and 48%,BMC Infectious Diseases 2007, 7:144 http://www.biomedcentral.com/1471-2334/7/144
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respectively, in 2005/06 (p for trend across seasons, 0.131
and 0.002, respectively).
Vaccination coverage in target groups
The vaccination coverage rate among those above 60 years
of age slightly decreased in the beginning of the observa-
tion period, but increased since season 2004/05 (see Fig-
ure 2a). A positive significant trend was noted over the
entire period. In all seasons, the vaccination rate was sig-
nificantly higher than in persons under 60 years of age (p
< 0.001). A question exploring the prevalence of chronic
illness was added to the questionnaire in 2003. Over the
three observed seasons, significantly higher vaccination
coverage rates were observed among the chronically ill
compared to the group without chronic diseases (Fig. 2b).
Furthermore, the vaccination rate among those with a
chronic disease increased over the years. Working in the
medical field did not seem to encourage vaccination. The
vaccination coverage rate among healthcare workers was
lower, but not significantly so, than the coverage rate in
the non-medical-professional group (Fig. 2c). The data
indicate that the vaccination rate among healthcare work-
ers has been increasing over the last three years, reaching
a high of 27.0% in 2005/06. For persons in the combined
target group, a significantly higher coverage rate was
observed compared to the non-target group respondents
(Fig. 2d). For the target group, a significant increase in vac-
cination rate was observed over the entire period (p <
0.001).
Influences on vaccination coverage
Vaccination rate differences across age were distinct. Older
age and adolescence were associated with higher vaccina-
tion rates compared to young adults. In season 2005/06
the uptake was higher for all age groups than in the previ-
ous season (see Figure 3).
Pooled data from the first four seasons show a higher vac-
cination rate among households with few children, a low
educational level, and low income. This was confirmed in
the 2005/06 data where even further increases were
observed. An increase in vaccination rate was also
observed among very high-income people, but remained
stable for middle size incomes in season 2005/06.
The trend curves illustrated in Figure 2 were not adjusted
for potential confounders. The corresponding, unadjusted
odds ratios are shown in Table 2. Adjusted odds ratios
(not shown) were investigated in the logistic regression
models. The adjustment took into account gender, age
Vaccination rate and intended vaccination rate Figure 1
Vaccination rate and intended vaccination rate.
p-value: Chi squared test for trend
Error bars: 95% Confidence interval
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Table 1: Overview of sample
2001/02 2002/03 2003/04 2004/05 2005/06 Total
Total (N) 1 988 1 990 2 006 1 994 2 012 9 990
Mean age (years) (95%CI) 46.7 (45.9; 47.5) 47.0 (46.2; 47.8) 46.9 (46.0; 47.7) 47.3 (46.5; 48.1) 47.5 (46.7; 48.3) 47.1 (46.7; 47.4)
Male (95%CI) 47.7% (45.5%; 49.9%) 47.8% (45.6%; 50.0%) 47.7% (45.5%; 49.9%) 47.8% (45.6%; 50.0%) 47.8% (45.6%; 50.0%) 47.8% (46.8%; 48.8%)
Age ≥ 60 years1 (95%CI) 28.9% (26.9%; 30.9%) 29.6% (27.6%; 31.6%) 29.6% (27.6%; 31.6%) 30.7% (28.7%; 32.7%) 30.6% (28.6%; 32.6%) 29.9% (29.0%; 30.8%)
Work in the medical 
field2 (95%CI)
6.8% (5.6%; 7.8%) 6.4% (5.3%; 7.5%) 6.4% (5.3%; 7.5%) 7.2% (6.1%; 8.3%) 7.3% (6.2%; 8.4%) 6.8% (6.3%; 7.3%)
Chronic illness3 (95%CI) NA NA 23.3% (21.4%; 25.1%) 24.2% (22.3%; 26.1%) 22.8% (20.9%; 24.5%) 23.4% (22.3%; 24.5%)
Target group 1 or 2 or 3 
(95%CI)
NA NA 46.2% (44.0%; 48.4%) 47.4% (45.2%; 49.6%) 47.1% (44.9%; 49.3%) 46.9% (45.6%; 48.2%)
NA: Not availableBMC Infectious Diseases 2007, 7:144 http://www.biomedcentral.com/1471-2334/7/144
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over 60 years, work in medical field, chronical illness,
level of education and income. For years where data on
chronic illness, level of education and household income
were not available, data were only adjusted for the
remaining covariates. The odds ratios for the combined
target group were only adjusted for age. In an additional
analysis, only persons below the age of 65 years were ana-
lysed.
Age 60 or older and chronic illness were independent sig-
nificant predictors of vaccination (unadjusted OR in
2005/06: 5.5). If only persons below the retirement age
(65 years) were included, an increased coverage rate in
healthcare workers became visible, and became signifi-
cant in season 2004/05 (multivariate adjusted OR in
2004/05: 1.5), but no other significant effects were
observed for this target group. In the chronically ill,
adjusting for age decreased the odds ratio of being vacci-
nated. These were the only substantial effects of multivar-
iate adjustment, i.e. all other odds ratios remained
substantially unchanged. Of the regression covariates not
representing target groups, higher household income was
significantly associated with a lower vaccination rate. No
independent associations with gender or level of educa-
tion were detected. Vaccinated population by age groups Figure 3
Vaccinated population by age groups.
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Trend curves of vaccination rates in high-risk groups (p values are for trend over time) Figure 2
Trend curves of vaccination rates in high-risk groups (p values are for trend over time). 2a. Age, 2b. Chronic illness, 2c. 
Working in the medical field, 2d. Combined target group.
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Drivers and barriers for vaccination
Among those who indicated that they had been vacci-
nated in the current season, the most frequently stated
reason was that influenza is considered to be a serious ill-
ness and I do not want to get it (see Table 3). Other impor-
tant reasons for getting vaccinated, not mentioned in
Table 3, was older age (38% in 2005/06) and that the
social security system pays for it (37% in 2005/06). The
attention on avian influenza and on influenza pandemics
had influenced the choice of getting vaccinated of 13%.
This subgroup was not statistically different from the
other vaccinated in terms of age, gender and risk of influ-
enza. However, the proportion of first time vaccinated
was higher among those who reported avian influenza as
a reason for vaccination (19.3% vs. 10.3%, p = 0.007).
The most common response from those never vaccinated
before was thinking about it without putting it into prac-
tice (Tab. 3). Not liking needles/injections was commonly
reported (31% in 2005/06). Being against vaccination was
considered a less important barrier (16% in 2005/06).
Persons previously vaccinated but not in the current sea-
son (2005/06), said that they did not feel concerned
(46%) or they did not think or about getting vaccinated/
they forgot (36%).
The knowledge about influenza vaccination was similar
across all seasons, despite the increased awareness of pan-
demic risk in the population. It is well-known that it is pos-
sible to catch influenza even if vaccinated, but that the infection
and side effects are then less severe (see Table 4). Response
rates on these questions were high in Germany compared
to the other European countries. Twenty-seven percent of
the surveyed subjects in Germany agreed with the state-
ment that the influenza vaccine would protect them
Table 3: Ranking of reasons for and against vaccination
2001/02 2002/03 2003/04 2004/05 2005/06
Reason for getting vaccinated – rank (%)
Because influenza is a serious illness and I did not want to get it 1 (83) 1 (90) 1 (90) 1 (89) 1 (88)
My family doctor/nurse advised me to do it 2 (66) 2 (72) 3 (70) 2 (73) 2 (68)
So that I do not pass influenza bug to my family and friends 3 (62) 3 (70) 2 (71) 3 (71) 3 (67)
Reasons for not getting vaccinated (among those never vaccinated) – rank (%)
I thought about it, but I did not end up getting vaccinated - 2 (44) 1 (52) 1 (52) 1 (50)
I do not think I am very likely to catch the flu 1 (38) 1 (47) 2 (41) 2 (41) 2 (44)
It is not a serious enough illness 2 (33) 4 (37) 4 (35) 5 (32) 3 (34)
My family doctor has never recommended it to me 4 (30) 5 (37) 3 (36) 3 (36) 4 (33)
My pharmacist has never recommended it to me - 3 (38) 5 (32) 6 (32) 5 (31)
I have never considered it before 3 (30) 6(31) 6 (31) 7 (32) 5 (31)
Table 2: Likelihood of vaccination coverage in target groups
2001/02 2002/03 2003/04 2004/05 2005/06
Age (<60*/≥60 yrs)
OR (95% CI) 4.3 (3.5; 5.3) 6.1 (4.9; 7.7) 3.8 (3.1; 4.7) 6.1 (4.9; 7.5) 5.5 (4.5; 6.8)
p-value <0.001 <0.001 <0.001 <0.001 <0.001
Work in the medical field (yes/no*)
OR (95% CI) 0.8 (0.6; 1.3) 0.5 (0.3; 0.8) 0.9 (0.6; 1.4) 0.9 (0.6; 1.3) 0.7 (0.5; 1.1)
p-value 0.110 0.026 0.204 0.672 0.151
Chronic illness (yes/no*)
OR (95% CI) - - 2.5 (2.0; 3.1) 3.6 (2.9; 4.5) 3.0 (2.4; 3.7)
p-value - - <0.001 <0.001 <0.001
Combined target group (age, work in medical field and chronic illness) (yes/no*)
OR (95% CI) - - 3.6 (2.9; 4.5) 5.2 (4.2; 6.5) 4.5 (3.6; 5.5)
p-value - - <0.001 <0.001 <0.001
OR = Odds Ratio (unadjusted). P-value (unadjusted): Pearson Chi squared. * Reference category.BMC Infectious Diseases 2007, 7:144 http://www.biomedcentral.com/1471-2334/7/144
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against avian influenza, although the majority of Ger-
mans disagreed with this statement (67%) (Tab. 4).
The survey also shows that a recommendation by the fam-
ily doctor, or knowing more about the efficacy and toler-
ability of the vaccine or about the disease would
encourage many people to get vaccinated. Moreover,
reimbursement or a cheaper price of the vaccine might sig-
nificantly change the level of influenza coverage in Ger-
many.
Discussion
In Germany, the overall vaccination rate increased signif-
icantly in season 2005/06 compared to season 2004/05.
The introduction of full reimbursement of vaccination in
the entire population by some insurers may have had a
direct influence on the increased vaccination rates [3].
Moreover, Germany has been particularly active in terms
of media coverage on avian influenza and the possible
shortage of antiviral agents. This has increased the popu-
lation's awareness of pandemic risks and may have influ-
enced vaccination coverage rates. The attention on
pandemics and avian influenza may also have encouraged
more doctors to recommend vaccination. The actual
impact of these potential influences requires further
study.
The overall vaccination rate in Europe was 26.5% in sea-
son 2005/06. Thus, the vaccination rate in Germany, at
32.5%, was above the European average in this year like in
the previous seasons [9]. Our observations on immunisa-
tion uptake in the German population are consistent with
findings from similar studies performed in Germany
[10,6,11].
Vaccination rate differences across age were distinct. Older
age and adolescence were associated with higher rates of
vaccination. In season 2005/06 the uptake was higher for
all age groups (Fig. 3). The increase is very clear in the age
group above 60 years, which seems to confirm an effect of
the vaccination campaigns. Important increases in the
population below the age of 60 may be explained by the
extension of reimbursement of influenza vaccination [3].
Another factor affecting vaccination rate is having a
chronic disease. Working in the medical field in Germany
did not seem to encourage vaccination. Earlier publica-
tions on influenza coverage rates note a low coverage in
health care workers in Germany [5,12-15]. Leitmeyer and
colleagues found a vaccination rate of 22% in season
2001/02 and 26% in season 2003/04 in 20 hospitals [12].
Hallauer and Neuschaefer-Rube found a vaccination rate
of 8.4% in season 2001/02 in 25 hospitals [13]. Buchholz
and colleagues reported a coverage level of 11.6% among
hospital staff in 2000/01 [15]. In comparison, we found a
range between 13% and 27% in the population between
2001 and 2006.
Over the last 5 years, most of the vaccinated believed that
influenza is a serious illness they do not want to get. The non-
vaccinated were thinking about it but never put it into prac-
tice, most likely because they did not think they were very
likely to catch the flu. Those previously vaccinated but not
in the current season (2005/06) said they did not feel con-
cerned, had not thought about it, or simply forgot. The
data confirms that the major encouraging factor to vacci-
nation is a recommendation from the family doctor or
nurse. This finding was confirmed in other publications
[5,8,9,11,16].
Of the 2005/06 respondents, 49.6% intend to get vacci-
nated in season 2006/07. The gap between intent to get vac-
cinated and actual vaccination was 15–20% over the years.
Hence, there is potential to increase vaccination coverage
rates in Germany in the future. To achieve vaccine uptake
approaching vaccination intention (49.6%), activation of
the correct drivers and dealing with the vaccination barri-
ers is to be further implemented in Germany.
Telephone interviews have been used on several occasions
to study the vaccination rate in Germany [5,6,8,9,11]. The
main advantage of telephone interviews is a potentially
high response rate obtained in an affordable and fast
manner. The selection process based on random drawing
of telephone numbers has been shown to be of high qual-
ity [17].
Table 4: Knowledge about influenza and vaccination from 2001 to 2006 (%)
Agree Disagree DK
You can catch influenza even if you are vaccinated against it 77.1 18.5 4.4
If you catch influenza after having had the vaccine, the infection is less severe 65.3 26.0 8.7
The side effects associated with the vaccine (fever, headache, etc.) are acceptable 59.0 28.9 12.1
It is important to get the influenza vaccine each year 56.1 41.8 2.1
The influenza vaccine is not useful if you are in good health 41.6 55.0 3.4
If you have the vaccine you will not catch influenza 34.4 61.7 3.9
The influenza vaccine will protect me in case of avian influenza/influenza pandemic (2005/06) 27.4 67.0 5.6
DK: Don't knowBMC Infectious Diseases 2007, 7:144 http://www.biomedcentral.com/1471-2334/7/144
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Several restrictions of the present evaluation are recog-
nized. The most important potential reason for selection
bias despite correct sampling is non response. However,
comparison of face-to-face, mailed and telephone surveys
addressing health-related issues, found only small differ-
ences between modes of administration and little non-
response effects with respect to prevalence estimates
[18,19]. Non-response in telephone surveys was found to
be less content-oriented than in mailed surveys [20]. Fur-
thermore, bias due to different sociodemographic charac-
teristics of persons not reachable by telephone affected
reports of illness and related use of medical services only
slightly, provided that the general population was
addressed and telephone coverage was at least 90%
[20,21]. These published findings support the validity of
our approach, although we had no means to independ-
ently confirm self-reported vaccination status.
The limitations of the present data collection were
described in greater detail in an earlier publication [9]. An
increasing problem is the use of wireless telephones. For
example, it was shown in the US that people with land-
lines had a higher odds (1.27) of being vaccinated than
those with only access to wireless telephones [22]. If this
is believed to be similar in Germany we might have
slightly over-estimated the vaccination rate.
Conclusion
The WHO considers the current influenza pandemic risk
to be on its highest level [4]. Efforts should be made at all
national and international levels to increase the coverage
according to the WHO objectives (i.e. 50% vaccination
coverage to be reached in the elderly in 2006 and 75% in
2010) [23]. German has managed to meet the goal as the
vaccination rate in the elderly ≥60 of age has reached
nearly 60% and 49% on average in all high-risk people.
Nonetheless there are still major efforts to be done to
reach the 2010 objectives.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
MH contributed to the data analysis and wrote the manu-
script. PB contributed to the draft and the final version of
the manuscript. TS designed the project, contributed to
the data acquisition and the analysis and supervised its
development.
All authors read and approved the final manuscript.
Acknowledgements
This study was made possible by an unrestricted research grant from Sanofi 
Pasteur MSD, Lyon, France. A special thank to Bertrand Verwee, Christine 
Pilet from Sanofi Pasteur, and to Matthias Schwenkglenks from the Euro-
pean Center of Pharmaceutical Medicine, Basel, Switzerland, for their com-
ments on the study and on the analysis of the data.
References
1. RKI: Influenza. RKI-Ratgeber Infektionskrankheiten – Merk-
blätter für ÄrzteZielgruppen der Impfung (laut Empfehlun-
gen der STIKO).  2006 [http://www.rki.de/cln_048/nn_200120/DE/
Content/Infekt/EpidBull/Merkblaetter/
Ratgeber__Mbl__Influenza.html]. (accessed 1 Jun 06)
2. Sozialministerium:  Bekanntmachung des Sozialministeriums
über öffentlich empholene Schutzimpfungen. Vom 13.
November 2001 - Az: 52-5423-1.1 - Baden-Württemberg.
2001.
3. Krankenkassen:  Zahlt meine Kasse für die Grippeschut-
zimpfung? www.krankenkassen.de (accessed 21 Sept 2006).
2006.
4. WHO: Current WHO phase of pandemic alert - November
2005.  2006 [http://www.who.int/csr/disease/avian_influenza/phase/
en/index.html]. (accessed 1 Jun 06)
5. Rehmet S, Ammon A, Pfaff G, Bocter N, Petersen LR: Cross-sec-
tional study on influenza vaccination, Germany, 1999-2000.
Emerg Infect Dis 2002, 8(12):1442-1447.
6. Wiese-Posselt M, Leitmeyer K, Hamouda O, Bocter N, Zollner I,
Haas W, Ammon A: Influenza vaccination coverage in adults
belonging to defined target groups, Germany, 2003/2004.
Vaccine 2006, 24(14):2560-2566.
7. Muller D, Wutzler P, Szucs TD: Influenza vaccination coverage
rates in Germany a population-based cross-sectional analysis
of the seasons 2002/2003 and 2003/2004.  Med Klin (Munich)
2005, 100(1):6-13.
8. Szucs TD, Wahle K, Müller D: [Influenza vaccination in Ger-
many. A population-based cross-sectional analysis of three
seasons between 2002 and 2005].  2006, 101(7):537-545. [Arti-
cle in German]
9. Szucs TD, Muller D: Influenza vaccination coverage rates in five
European countries-a population-based cross-sectional anal-
ysis of two consecutive influenza seasons.  Vaccine 2005,
23(43):5055-5063.
10. Robert Koch-Institute: Teilnahme an Influenza- und
Pneumokokken-Schutzimfung.  Epidemiologisches Bull 2002,
16:123-131.
11. Kroneman M, van Essen GA, John Paget W: Influenza vaccination
coverage and reasons to refrain among high-risk persons in
four European countries.  Vaccine 2006, 24(5):622-628.
12. Leitmeyer K, Buchholz U, Kramer M, Schenkel K, Stahlhut H, Kölls-
tadt M, Haas W, Meyer C: Influenza vaccination in German
health care workers: effects and findings after two rounds of
a nationwide awareness campaign.  Vaccine 2006, 24(47-
48):7003-7008.
13. Hallauer JF, Neuschaefer-Rube N: Influenza vaccination of hospi-
tal staff in Germany: a five-year survey on vaccination cover-
age and policies: identified deficits in influenza immunisation
campaigns for hospital employees.  Soz Praventivmed 2005,
50(1):38-44.
14. Kroneman M, Paget WJ, van Essen GA: Influenza vaccination in
Europe: an inventory of strategies to reach target popula-
tions and optimise vaccination uptake.  Euro Surveill 2003,
8(6):130-138.
15. Buchholz U: Überraschende Defizite in deutschen Kranken-
häusern.  Dt Aerzteblatt 2002, 99:A2460-1.
16. Kamal KM, Madhavan SS, Amonkar MM: Determinants of adult
influenza and pneumonia immunization rates.  J Am Pharm
Assoc (2003) 2003, 43(3):403-411.
17. Streiner DL, Norman GR: Health Measurement Scales. A Prac-
tical Guide To Their Development And Use.  Oxford, New
York , Oxford University Press Inc.; 1995. 
18. Marcus AC, Crane LA: Telephone surveys in public health
research.  Med Care 1986, 24:97-112.
19. O'Toole BI, Battistutta D, Long A, Crouch K: A comparison of
costs and data quality of three health survey methods: mail,
telephone and personal home interview.  Am J Epidemiol 1986,
124(2):317-328.
20. Fowler FJ Jr., Gallagher PM, Stringfellow VL, Zaslavsky AM, Thompson
JW, Cleary PD: Using telephone interviews to reduce nonre-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Infectious Diseases 2007, 7:144 http://www.biomedcentral.com/1471-2334/7/144
Page 8 of 8
(page number not for citation purposes)
sponse bias to mail surveys of health plan members.  Med Care
2002, 40(3):190-200.
21. Ford ES: Characteristics of survey participants with and with-
out a telephone: findings from the third National Health and
Nutrition Examination Survey.  J Clin Epidemiol 1998,
51(1):55-60.
22. Blumberg SJ, Luke JV, Cynamon ML: Telephone coverage and
health survey estimates: evaluating the need for concern
about wireless substitution.  Am J Public Health 2006,
96(5):926-931.
23. WHO:  Resolution of the World Health Assembly WHA
56.19, Prevention and control of influenza pandemics and
annual epidemics, 56th WHA, 10th plenary meeting, 28 May,
2003.  2003.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2334/7/144/pre
pub